Tag: opioid use disorder

spot_imgspot_img

The Decline in Buprenorphine Dispensing to Young People: A Closer Look at the Trends, Barriers, and Opportunities for Improvement

Opioid use disorder (OUD) remains a major public health crisis, particularly among young people. Medication-assisted treatment (MAT), which includes buprenorphine, has been recognized as...

Addressing the Urgent Need for Medication-Assisted Treatment for Opioid Use Disorder in Medicare Beneficiaries

The opioid crisis continues to devastate communities across the United States, and while efforts to combat the epidemic have been ongoing, certain populations, particularly...

The Impact of Telehealth for Opioid Use Disorder Treatment Retention During the COVID-19 Pandemic

The COVID-19 pandemic fundamentally changed the healthcare landscape, presenting both challenges and opportunities. One of the more concerning trends during this period was the...

The Gold Standard in Opioid Use Disorder Treatment: Addressing Access Challenges and the Growing Concern of Buprenorphine Diversion

Medication-based treatment has long been recognized as the gold standard for treating opioid use disorder (OUD). Medications like buprenorphine are widely regarded for their...

The Importance of Medication-Assisted Treatment for Opioid Use Disorder: Why Non-Opioid Options May Not Be Enough

Medication-assisted treatment (MAT) has long been recognized as the gold standard in treating opioid use disorder (OUD). Medications such as methadone and buprenorphine, both...

Exploring the Impact of Medicaid Waivers on Opioid Use Disorder Treatment

Exploring the Impact of Medicaid Waivers on Opioid Use Disorder Treatment In 2015, the Centers for Medicare and Medicaid Services (CMS) made a transformative change...